ENDRA Life Sciences NDRA
NASDAQ NDRA
$4.63 +0.22 (+5.11%)
As of: Oct 21, 2026 · 1:41 PM EDT

ENDRA Life Sciences (NDRA) Liabilities and Shareholders Equity (2016 - 2026)

Updated

ENDRA Life Sciences (NDRA) posted Liabilities and Shareholders Equity of $7.94 million for Q2 2026, up 182.9% from $2.81 million a year earlier and up 131.0% from the prior quarter.

Analysis

ENDRA Life Sciences (NDRA) Liabilities and Shareholders Equity (2016 - 2026) Analysis & Trends

At the end of FY2025, ENDRA Life Sciences' Liabilities and Shareholders Equity came in at $3.85 million, down 13.4% from FY2024.

  • Annual Liabilities and Shareholders Equity has declined for four consecutive years, with a five-year compound annual growth rate of -15.2% (FY2020 to FY2025).
  • In prior years, ENDRA Life Sciences' Liabilities and Shareholders Equity was $4.45 million in FY2024 (-34.1%), $6.75 million in FY2023 (-27.2%), $9.27 million in FY2022 (-28.0%) and $12.87 million in FY2021 (+46.9%).
  • The Q2 2026 figure stands as the highest quarterly Liabilities and Shareholders Equity since Q3 2024.
  • On a year-over-year basis, Liabilities and Shareholders Equity increased in three of the last eight quarters, with an average decline of 4.1%.
  • The strongest year-over-year quarter for Liabilities and Shareholders Equity in the past five years was Q3 2021, with growth of 185.6%; the weakest was Q3 2025, with a decline of 76.6%.
  • According to Business Quant data, Liabilities and Shareholders Equity for the three prior quarters was $3.44 million (Q1 2026), $3.85 million (Q4 2025) and $1.96 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Thermo Fisher Scientific 257.25 Bn 236.28 Bn 4.88 Bn 113.17 Bn
2 Abbott Laboratories 171.30 Bn 141.73 Bn 7.27 Bn 109.22 Bn
3 Danaher 162.82 Bn 146.63 Bn 3.61 Bn 92.37 Bn
4 Intuitive Surgical 151.42 Bn 130.84 Bn 1.96 Bn 20.88 Bn
5 Medtronic 119.73 Bn 84.98 Bn 6.34 Bn 93.31 Bn
6 Stryker 113.93 Bn 100.05 Bn 4.50 Bn 47.93 Bn
7 Boston Scientific 65.31 Bn 60.07 Bn 3.85 Bn 45.22 Bn
8 Becton Dickinson 53.55 Bn 50.70 Bn 2.32 Bn 50.73 Bn
9 Edwards Lifesciences 50.87 Bn 34.87 Bn 1.35 Bn 13.87 Bn
10 ENDRA Life Sciences 6.13 Mn 2.48 Mn - 7.94 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.94 Mn
Mar 31, 2026 3.44 Mn
Dec 31, 2025 3.85 Mn
Sep 30, 2025 1.96 Mn
Jun 30, 2025 2.81 Mn
Mar 31, 2025 3.17 Mn
Dec 31, 2024 4.45 Mn
Sep 30, 2024 8.38 Mn
Jun 30, 2024 10.44 Mn
Mar 31, 2024 5.06 Mn
Dec 31, 2023 6.75 Mn
Sep 30, 2023 7.60 Mn
Jun 30, 2023 9.24 Mn
Mar 31, 2023 6.65 Mn
Dec 31, 2022 9.27 Mn
Sep 30, 2022 12.34 Mn
Jun 30, 2022 15.31 Mn
Mar 31, 2022 10.94 Mn
Dec 31, 2021 12.87 Mn
Sep 30, 2021 15.31 Mn
API Access

ENDRA Life Sciences Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=NDRA&period=max&api_key=YOUR_API_KEY